In one paragraphArticle in Arthritis & rheumatology (Hoboken, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
4 authors.
Sharan K RaiMassachusetts General Hospital, Harvard Medical School, Channing Division of Network Medicine, and The Mongan Institute, General Hospital, Boston, and Arthritis Research Canada, Vancouver, British Columbia, Canada.
Hyon K ChoiMassachusetts General Hospital, Harvard Medical School, Channing Division of Network Medicine, and The Mongan Institute, General Hospital, Boston, and Arthritis Research Canada, Vancouver, British Columbia, Canada.
Natalie McCormickMassachusetts General Hospital, Harvard Medical School, Channing Division of Network Medicine, and The Mongan Institute, General Hospital, Boston, and Arthritis Research Canada, Vancouver, British Columbia, Canada.ORCID https://orcid.org/0000-0002-4147-8348 Funding
Life Course Cancer Epidemiology Cohort in WomenU01CA176726 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI ELIASSEN, A. HEATHER, WILLETT, WALTER C. · 2018 to 2025
$22.4MLong Term Multidisciplinary Study of Cancer in Women: The Nurses Health StudyUM1CA186107 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ELIASSEN, A. HEATHER, STAMPFER, MEIR · 2014 to 2023
$22.3MCancer Epidemiology Cohort in Male Health ProfessionalsU01CA167552 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Lorelei Mucci, Walter C. Willett · 2017 to 2026
$17.0MThe Effects of Urate Lowering Therapy on Inflammation, Endothelial function, andP50AR060772 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SAAG, KENNETH G · 2012 to 2021
$12.8MNOVEL METABOLITE AND MICROBIOTA PATHWAYS FOR HYPERURICEMIA AND GOUTR01AR065944 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI CHOI, HYON K · 2013 to 2025
$4.2MPersonalized Comorbidity-Integrated Gout CareK23AR081425 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI Chio Yokose · 2023 to 2026
$704kMetabolic syndrome, chronic inflammation, and gout: a multi-omics approachR00AR080243 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI Natalie McCormick · 2025 to 2026
$461kMetabolic syndrome, chronic inflammation, and gout: a multi-omics approachK99AR080243 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI MCCORMICK, NATALIE · 2022 to 2023
$188kCIHR Fellowship AwardNCI NIH HHS U01 CA167552NCI NIH HHS U01 CA176726NCI NIH HHS UM1 CA186107NIAMS NIH HHS K23 AR081425NIAMS NIH HHS K23-AR081425NIAMS NIH HHS K99 AR080243NIAMS NIH HHS K99-AR080243NIAMS NIH HHS P50 AR060772NIAMS NIH HHS P50-AR-060772NIAMS NIH HHS R00 AR080243NIAMS NIH HHS R01 AR065944
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID40184258
PMCPMC12353026
What Socratic holds
Textmetadata
LicenceTDM
Read underepoch 390